Please assess the completion status of the following clinical trial:

Trial Title: Preoperative High-dose Dexamethasone and Emergency Laparotomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults (18 years or over) undergoing emergency laparotomy (laparotomy or laparoscopy) for following abdominal pathology:~   1. Primary perforated viscus (perforated ulcer, small intestine or colon)~  2. Primary intestinal obstruction ( small intestine or colon)~2. Provided verbal and written informed consent~3. Must speak and understand the Danish language~Exclusion Criteria:~1. Appendectomies, cholecystectomies, negative diagnostic laparoscopies/laparotomies, herniotomies without bowel resections, sub-acute internal hernias after gastric bypass surgery, sub-acute surgery for inflammatory bowel diseases.~2. Emergency re-operations after elective surgery owing to paralytic/obstructive ileus, perforated viscus, anastomotic leakage~3. Reoperation owing to fascial separation with no other abdominal pathology identified and sub-acute colorectal cancer-surgery will be excluded from the cohort. Sub-acute surgery is defined as surgery planned within 48 hours.~4. Intestinal Ischemia~5. intraabdominal bleeding~6. Traumas, gynecological, urogenital and other vascular pathology, pregnant participants.~7. Dementia and/or cognitive dysfunction (diagnosed).~8. Participants not oriented in time, place and person~9. Insuline treatment for diabetes mellitus type I and II~10. Current treatment with systemic glucocorticoids or immune suppressive treatment ( apart from inhalation steroids)~11. Allergies to trial medicine~    -

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intestinal obstruction, Dexamethasone 1 mg/kg (Type: ACTIVE_COMPARATOR): Dexamethasone 1 mg/kg administered preoperatively as an i.v. infusion over 10-15 minutes
- Intestinal obstruction, PLACEBO (Type: PLACEBO_COMPARATOR): Physiologic saline, administered preoperatively as an i.v. infusion over 10-15 minutes
- Perforated viscus, Dexamethasone 1 mg/kg (Type: ACTIVE_COMPARATOR): Dexamethasone 1 mg/kg administered preoperatively as an i.v. infusion over 10-15 minutes
- Perforated viscus, PLACEBO (Type: PLACEBO_COMPARATOR): Physiologic saline, administered preoperatively as an i.v. infusion over 10-15 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).